47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73 - Advertising, market research and public relations
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,1 | 2,6 | 2,4 | -7,7 |
Gross profit (loss) | 2,4 | 2,7 | 2,5 | -7,5 |
EBITDA | 2,5 | 2,7 | 2,6 | -7,2 |
Short time liabilities | 1,4 | 1,8 | 2,4 | 31 |
Other operating costs | 0 | 0 | 0 | 314,8 |
Equity capital | 2,7 | 3 | 2,8 | -6,9 |
Operating profit (EBIT) | 2,4 | 2,7 | 2,5 | -7,5 |
Assets | 4,3 | 4,9 | 5,2 | 6 |
Net profit (loss) | 2,4 | 2,7 | 2,5 | -7,5 |
Cash | 1,2 | 1,2 | 0,6 | -47,2 |
Liabilities and provisions for liabilities | 1,6 | 1,9 | 2,4 | 26 |
Net income from sale | 19,3 | 23 | 25,2 | 9,7 |
Working assets | 4,3 | 4,8 | 5,1 | 5,8 |
Other income costs | 0,4 | 0,1 | 0,1 | -1,6 |
Depreciation | 0 | 0 | 0 | 31,3 |
% | % | % | p.p. | |
Profitability of capital | 90,4 | 91,3 | 90,6 | -0,7 |
Equity capital to total assets | 62,2 | 60,8 | 53,4 | -7,4 |
Gross profit margin | 12,6 | 11,9 | 10 | -1,9 |
EBITDA Margin | 12,8 | 12 | 10,1 | -1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 27 | 29 | 35 | 6 |
Current financial liquidity indicator | 2.992896795272827 | 2.613992691040039 | 2.111440896987915 | -0,5 |
Net dept to EBITDA | -0.4019656181335449 | -0.4087103009223938 | -0.2476237714290619 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane